Skip to main content
SpringerLink
Log in

Identification of GM2-gangliosidosis B1 variant carriers

  • Published:
Journal of Inherited Metabolic Disease

Summary

GM2-gangliosidosis B1 variant, considered a rare disorder with a wide geographical and ethnic distribution, appears to be exceptionally frequent in Portugal. In order to establish a carrier detection method for this disease we have determined the ratio of enzymatic activities against 4MUGS and 4MUG in urine from B1 variant obligate carriers and controls, using the total extract and the Hex A immunobound to a monoclonal antibody. The Hex A immunoassay was applied to the identification of carriers in B1 variant families and the results obtained were compared with those from DNA analysis. The reliability and feasibility of the Hex A immunoassay make it a suitable method for B1 variant carrier screening, which is particularly important for the prevention of this severe neurological disease in the population at risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aerts JMFG, Sa Miranda MC, Wanzeller de Lacerda L et al (1991) The identification of type 1 Gaucher disease patients, asymptomatic cases and carriers in The Netherlands using urine samples: an evaluation.Clin Chim Acta 203: 349–362.

    Google Scholar 

  • Ainsworth PJ, Coulter-Mackie MB (1992) A double mutation in exon 6 of the β-hexosaminidase α-subunit in a patient with the B1 variant of Tay-Sachs disease.Am J Hum Genet 51: 802–809.

    Google Scholar 

  • Conover WJ (1980)Practical Nonparametric Statistics, 2nd edn. New York: Wiley.

    Google Scholar 

  • Dos Santos MR, Tanaka A, Sa Miranda MC, Ribeiro MG, Maia M, Suzuki K (1991) GM2-gangliosidosis B1 variant: analysis of β-hexosaminidase α gene mutations in 11 patients from a defined region in Portugal.Am J Hum Genet 49: 886–890.

    Google Scholar 

  • Fernandes M, Kaplan F, Natowicz M et al (1992) A new Tay-Sachs disease B1 allele in exon 7 in two compound heterozygotes each with a second novel mutation.Hum Mol Genet 1: 759–761.

    Google Scholar 

  • Hultberg B, Isaksson A (1989) Enzyme immunoassay of β-hexosaminidase isoenzymes in human urine and renal cortex with monoclonal antibodies.Enzyme 42: 25–30.

    Google Scholar 

  • Inui K, Wenger D (1984) Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-β-D-glucopyranoside for the diagnosis of GM2 gangliosidosis in leukocytes.Clin Genet 26: 318–321.

    Google Scholar 

  • Kytzia H-J, Hinnrichs U, Maire I, Suzuki K, Sandhoff K (1983) Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.EMBO J 2: 1201–1205.

    Google Scholar 

  • Kytzia H-J, Sandhoff K (1985) Evidence for two different active sites on human β-hexosaminidase A. Interaction of GM2 activator protein with β-hexosaminidase A.J Biol Chem 260: 7568–7572.

    Google Scholar 

  • Maia MC, Alves D, Ribeiro MG, Pinto R, Sa Miranda MC (1990) Juvenile GM2 gangliosidoses variant B1: Clinical and biochemical study in seven patients.Neuropediatrics 21: 18–23.

    Google Scholar 

  • Mayall E, Williams C (1990) A method for routinely extracting DNA buccal cells for cystic fibrosis carrier screening.J Med Genet 27: 658.

    Google Scholar 

  • Ohno K, Suzuki K (1988) Mutation in GM2-gangliosidosis B1 variant.J Neurochem 50: 316–318.

    Google Scholar 

  • Ribeiro MG, Pinto RA, Dos Santos MR, Maia M, Sa Miranda MC (1991) Biochemical characterization of β-hexosaminidase in different biological specimens from eleven patients with GM2-gangliosidosis B1 variant.J Inher Metab Dis 14: 715–720.

    Google Scholar 

  • Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989) The GM2 gangliosidosis. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds.The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 1807–1838.

    Google Scholar 

  • Sonderfeld S, Brendler S, Sandhoff K, Galjaard H, Hoogeveen AT (1985) Genetic complementation in somatic cell hybrids of four variants of infantile GM2-gangliosidosis.Hum Genet 71: 196–200.

    Google Scholar 

  • Stirling JL (1984) β-N-Acetylhexosaminidase. In Bergmeyer HU, ed.Methods of Enzymatic Analysis, vol. IV, 3rd edn. Weinheim: Verlag Chemie, 269–277.

    Google Scholar 

  • Tanaka A, Ohno K, Sandhoff K et al (1990) GM2-gangliosidosis B1 variant: Analysis of β-hexosaminidase α gene abnormalities in seven patients.Am J Hum Genet 46: 329–339.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Genética Médica Jacinto de Magalhaes, Pç. Pedro Nunes, 74, 4000, Porto, Portugal

    M. G. Ribeiro, R. Pinto & M. C. Sá Miranda

  2. Departamento de Produçao e Sistemas, Universidade do Minho, 4700, Braga, Portugal

    P. Oliveira

Authors
  1. M. G. Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Pinto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. C. Sá Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribeiro, M.G., Pinto, R., Oliveira, P. et al. Identification of GM2-gangliosidosis B1 variant carriers. J Inherit Metab Dis 16, 1003–1011 (1993). https://doi.org/10.1007/BF00711518

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00711518

Keywords

Search

Navigation